Viral illnesses
Early Ambulatory Multidrug Therapy Procter McCullough
Summary This study examined early ambulatory multidrug therapy for high risk COVID 19 patients to reduce hospitalisation and death rates. The research included 869 cases, with 320 cases from April to September 2020 and 549 cases from September to December 2020. The treatment protocol involved antiviral agents, antibiotics, inhaled medications, and intravenous supplements. In the
UK Vaccine Report Week 42
Summary The latest UK COVID 19 vaccine surveillance report for week 42 shows various vaccines are effective against symptomatic disease, especially the Delta variant. Vaccination coverage is high in older age groups, with reduced transmission risk and lower rates of cases, hospitalisations, and deaths in vaccinated individuals. The report also includes data on emergency care
Analysis Cost Benefit By Age Kirsch
Summary The analysis by Steve Kirsch concludes that COVID vaccines are more harmful than beneficial for all age groups and advocates for halting vaccinations in favour of early treatment protocols. The paper calculates the risks of vaccination compared to the assumed benefits and finds that vaccines may kill more people than they save. Various sources,
FLCCC I MASK Plus Protocol
Summary The document outlines the I MASK+ Protocol for COVID 19 prevention and early outpatient treatment, including the use of ivermectin and other medications, as well as general preventive measures like wearing masks and hand hygiene. It emphasises the importance of vaccines and early treatment in consultation with healthcare providers. The protocol includes dosing guidelines,
Comprehensive investigations revealed consistent pathophysiological alterations after vaccination
Summary The study examined immune responses following vaccination with inactivated SARS CoV 2, revealing alterations in gene expression in immune cell types. These changes included heightened NF κB signalling and reduced type I interferon responses, resembling patterns seen in COVID 19 patients. Clinical laboratory findings post vaccination showed electrolyte imbalances, coagulation profile shifts, and renal
Pfizer vaccine Effects Herve Seligmann Evaluation
The document by Hervé Seligmann evaluates the effects of the Pfizer COVID 19 vaccine. It raises concerns about potential adverse effects and the adequacy of clinical trial data. The analysis suggests that there may be underreporting of negative outcomes and emphasises the importance of comprehensive post vaccination monitoring to ensure safety and efficacy. The report
US COVID 19 Vaccines Proven to Cause More Harm than Good
The document argues that COVID 19 vaccines cause more harm than good based on the analysis of all cause severe morbidity as a scientific endpoint. It claims that the vaccines lead to an increase in severe health outcomes, including hospitalizations and deaths, outweighing their benefits. The report calls for reevaluation of the vaccine programs, citing
Coronavirus spreading among the vaccinated in highly vaccinated countries
The document discusses the spread of COVID 19 among vaccinated individuals in highly vaccinated countries, highlighting data from the UK, Israel, Chile, Seychelles, and Mongolia. It reports significant numbers of new symptomatic COVID 19 cases among the vaccinated, with the vaccinated populations in these countries experiencing higher or comparable infection rates to the unvaccinated. The